These two reports address the effects of varicella-zoster ... vaccine recipients than among placebo recipients (0.6% vs. 0.4%), for unknown reasons. The review authors recommend vaccine ...
recombinant zoster vaccine (RZV) and adjuvanted quadrivalent formulation (aIIV4), among older adults. "From a safety standpoint, this study supports the simultaneous administration of RZV and ...
Sareen, PharmD The second dose of Shingrix (recombinant zoster vaccine) may cause side effects ... In 2017, the Food and Drug Administration (FDA) approved Shingrix for the prevention of shingles ...